Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.22.0.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Accounts receivables and contract assets, allowance for credit losses $ 28,000,000 $ 33,000,000
Long-term Debt, Fair Value 268,000,000  
Redeemable preferred stock, par value $ 0.01 $ 0.01
Redeemable preferred stock, shares authorized 50,000,000 50,000,000
Redeemable preferred stock, shares issued 187,414 325,000
Redeemable preferred stock, shares outstanding 187,414 325,000
Series A    
Equity:    
Common stock, par value per share $ 0.01 $ 0.01
Common stock, shares authorized 200,000,000 200,000,000
Common stock shares issued 72,447,462 72,227,256
Common stock, shares outstanding 72,447,462 72,227,256
Series B    
Equity:    
Common stock, par value per share $ 0.01 $ 0.01
Common stock, shares authorized 7,500,000 7,500,000
Common stock shares issued 3,216,047 2,973,665
Common stock, shares outstanding 3,216,047 2,973,665
Series C    
Equity:    
Common stock, par value per share $ 0.01 $ 0.01
Common stock, shares authorized 200,000,000 200,000,000
Common stock shares issued 0 0